9^th conference of FIAPAC
In cooperation with ACAI, Spain
Seville, 22/23 October 2010
Achieving Excellence in Abortion Care

Registration

08.00

Opening

08.30

M.Parachini

Spanish official

Plenary 1

15 min. per speaker

09.00 -10.30

Global trends in abortion and contraception

Chairs: M. Parachini, E. Rodriguez

• Global overview

S.Henshaw, USA

• Overview from Europe

G.Lazdane, WHO

• EU networking in sexual and reproductive health and rights

Å.Régner, Sweden

• Overview from Latin America

M.Roa, Colombia

• Overview from Asia

N.Boonthai, Thailand

10.30 –11.00

Coffee

Plenary 2

15 min. per speaker

11.00 -12.30

Contraception

Chairs: S. Cameron, R. Moullier

• Why are contraceptives not used?

J.Bitzer,
Switzerland

• OC without prescription

A.Kubba, UK

• 'Natural' contraception

C.Fiala, Austria

• News in Emergency Contraception

 K.Gemzell, Sweden

• IUD post-abortion

O.Heikinheimo,

   Finland

12.30-14.00

Lunch

Workshop A

14.00-15.30

ICMA/Eastern European Alliance for Reproductive Choice (EEARC)

Abortion in Eastern European Countries: Challenges, Perspectives and Solutions

Chairs: R.Comendant, P.Hall

• Reproductive rights of women seeking abortion

G.Maistruc, Ukraine

• Safe abortion: Policy and Religion

V.Grebinskis, Lithuania

• Challenges and perspectives in Advocacy of safe abortion

D.Dragichi, Romania

• Reproductive Choices in HIV positive women

S.Posochova, Ukraine

Workshop B

14.00-15.30

Technical details of 1^st trimester surgical abortion

Chairs: M. Alblas, T. Schipper

• Anaesthesia: local v. general 

E.Arisi, Italy

• Very early surgical abortion

P.Lohr, UK

• Verifying successful aspiration, routine ultrasound etc

E.Wiebe, Canada

• Cervical priming

H.von Hertzen,

   Switzerland

Workshop C

14.00-15.30

Pre-abortion examinations/workup

Chairs: O. Heikinheimo,
            A Verougstraete 

• Post-abortal infection. Prevention strategies; screening v. prophylaxis incl. surgical -medical abortion European practice

S.Cameron, UK

• American practice and overview of the Clostridium infections

M.Fjerstad, USA

• Other pre abortion examinations: practices and evidence

C.Fiala, Austria

Workshop D

14.00-15.30

Free communications

Chairs: K. Oppegaard, K. Gemzell

15.30-16.00

Coffee

Plenary 3

16.00-17.30

Late abortion

Chair: B. Kothé, M Parachini

• Surgical abortion

E.Oloto, UK

• Medical abortion,including is fetocide needed? If so, when and how?

A.Templeton, UK

• Experience from Spain

M.Vidot, Spain

• Care (special considerations; psychological, physical: contraception, adolescence)

I-M.Andersson, Sweden

18.00-19.30

General Assembly

20.00

Reception

21:00

Dinner & Flamenco show

Plenary 4

09.00-10.30

Session on legal aspects

Chairs: S. Rowlands, G. Lazdane

• Working within existing legal frameworks to improve access to abortion

J.Erdmann, Canada

• The campaign to liberalise the law in Spain

E.Rodriguez, Spain

• Impact of legalising abortion in Portugal in 2007

M.Carvallo, Portugal

• Experiences of decriminalising abortion in Victoria, Australia

L.Cannold, Australia

10.30-11.00

Coffee

Workshop E

11.00-12.30

Medical abortion- improving access

Chairs; OE. Iversen, E. Aubény

• Medabon introduced by Concept Foundation

P.Hall, Switzerland 

• Medical abortion at 9-13 weeks

A.Templeton, UK 

• How to handle side-effects in medical abortion: bleeding, pain

P.Lefèbvre, 
France

Workshop F

11.00-12.30

Abortion counselling

Chairs: M. Berer, M. Francès

• The decision-making process

S.Rowlands, UK

• Working with mandatory counselling

U.Ellerstorfer,
Germany

• Working with cooling off periods        

L.van Crombrugge,
Belgium

• Working with parental authorisation requirements for minors

C.Chery,
Luxembourg

Workshop G

WHO session 

Chairs: A. Seidenberg, C. Fiala

• WHO tools and activities addressing unsafe abortion.

R.Johnson, WHO,

Switzerland

• Experience of application of WHO tools and guidelines in the WHO European Region in improving quality of abortion services

G.Lazdane,
WHO,
Europe 

• Implementation of WHO guidance  in Moldova

R.Comendant,
Moldavia

• How services in the Netherlands benefit from WHO guidance on abortion

B.van Herk,

   Netherlands

Workshop H

ESC session

Chairs: J. Bitzer, M. Lech

• New progestogens in contraception

R.Sitruk-Ware,
   USA 

• Quick start and extended use of OCs

A.Verougstraete
Belgium

• Contraception and obesity

J.Brynhildsen,
Sweden

• Post-abortion contraception

G.Merki,
Switzerland

12.30-14.00

Lunch

Workshop I

14.00-15.30

IPPF, The role of NGOs in ensuring safe abortion care

Chairs: C. Vrancken. Belgium, P. Lefèbvre, France

• NGO providing information and technical skills to service providers (following the law reform in Portugal)

D.Vilar,
Portugal

• The Family Planning Association of Nepal's experience in providing  abortion care

P.Thapa,
Nepal 

• Young people and abortion, Case study from Kyrgyzstan

 T.Popovitskaya,
 Kyrgyzstan

• NGO providing support to improve the quality of abortion services in a government clinic , Case study from Armenia

 M.Khachikyan,
 Armenia

• Young people advocating for access to abortion services, Case study from Ireland

 N.Behan,
 Ireland

Workshop J

14.00-15.30

Training / Education

Chairs: G.Halder, A. Templeton

• Undergraduate and postgraduate training of health care professionals in the UK

K.Guthrie, UK

• Training of abortion providers: how and when

V.Saporta, USA 

• Experiences from training in low resource settings

D.Hassoun, France

Workshop K

14.00-15.30

Misoprostol:

Chairs: K. Gemzell, H. von Hertzen

• Missed and incomplete abortion

B.Winikoff. USA 

• Misoprostol alone regimens for early and late abortion

J.Carbonell, Spain 

• Cervical dilatation in non pregnant pre- and postmenopausal women

K.Sunde
   Oppegaard,
   Norway

Workshop L

14.00-15.30

Free communications

Chairs: L. Van Crombrugge, S. Rowlands

15.30-16.00

Coffee

Plenary 5

16.00-17.30

Medical abortion

Chairs: M. Bygdeman, E. Aubény

• Medical abortion in a private practice: experiences from France

S.Gaudu,
France

• Medical abortion in adolescents

M.Niinimäki,
Finland

• Home-use of misoprostol in medical abortion up to 63days gestation

H.KoppKallner,
Sweden

• Medical abortion via the internet

R.Gomperts,Netherlands

Closing plenary

17.30-18.30

Closing session

Chairs; M. Parachini, C. Fiala

• Conclusions 

Spanish official

M.Berer , ICMA, UK 

Å.Régner,
Sweden

A.Furedi, UK

• Closing Remarks

M.Parachini